News

Article

Pharmaceutical Technology

Pharmaceutical Technology-05-02-2004
Volume28
Issue 5

aaiPharma Situation Underscores The Need for Due Diligence

Author(s):

Jim Miller

Sponsors who have been lax in performing financial due diligence on their contractors have been given a wake-up call by the recent developments at aaiPharma.

External Link - article-94551.pdf

Articles in this issue
i18_t-143862-1408695846297.jpg
Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology
An LC Method for the Separation and Determination of Ethynodiol Diacetate and Ethinyl Estradiol in Tablets
In The Spotlight-May 2004
FDA Eyes Manufacturing Innovation to Boost Drug Development
Prepare for Bar Coding
Validation and Compliance: Software Systems Prepare Manufacturers for Com(PAT)ibility
aaiPharma Situation Underscores The Need for Due Diligence
Excipient Functionality
Characterization of the Performance of Bin Blenders Part 1 of 3: Methodology
May 2004

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Related Content
Sand running through the bulbs of an hourglass | Image Credit: © BillionPhotos.com - stock.adobe.com
July 24th 2025

Customizable Relationships Enhance Speed to Market

Patrick Lavery
While a one-stop shop still has its advantages, sponsor companies and CDMOs are starting to see each other not as transactional relationships, but true partners with a common goal of getting drugs to patients faster.
Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends
July 11th 2023

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.
Sterile capsules for injection. Bottles on the bottling line of the pharmaceutical plant. Machine after checking sterile liquids. Interferon, nasoferon. | Image Credit: © neznamov1984 - stock.adobe.com
July 1st 2025

ten23 health Joins Gerresheimer, SCHOTT, Stevanato Group in ‘Alliance for RTU’

Patrick Lavery
The partnership was formed in September 2024 in response to increasing demand for aseptic filling technologies and processes.
Drug Solutions Podcast: Examining the State of Biopharma Investment
June 6th 2023

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.
Close up the media plate on hand medical technicians working on bacterial culture and drug resistance of pathogens in laboratory. | Image Credit: © analysis121980 - stock.adobe.com
June 26th 2025

Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics

Patrick Lavery
Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
June 25th 2025

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

Susan Haigney
Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.